XML 98 R83.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity (SARs Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Aug. 31, 2018
Aug. 31, 2017
SARS Outstanding    
SARS canceled (in shares) (35,439)  
SARs    
SARS Outstanding    
SARS Outstanding as of beginning of period (in shares) 319,241  
SARS canceled (in shares) (35,439)  
SARS exercised (in shares) (127,001)  
SARS Outstanding as of end of period (in shares) 156,801 319,241
SARS, Exercisable (in shares) 319,241  
Aggregate Intrinsic Value, Outstanding $ 1,748 $ 3,651
Aggregate Intrinsic Value, Exercisable $ 3,651  
Weighted- Average Exercise Price    
Weighted-Average Exercise Price, Outstanding as of beginning of period (in dollars per share) $ 19.91  
Weighted-Average Exercise Price, SARS canceled (in dollars per share) 21.56  
Weighted-Average Exercise Price, SARS exercised (in dollars per share) 21.31  
Weighted-Average Exercise Price, Outstanding as of end of period (in dollars per share) 18.41 $ 19.91
Weighted-Average Exercise Price, Exercisable (in dollars per share) $ 18.41  
Weighted- Average Remaining Contractual Life, Outstanding 3 years 1 month 6 days 2 years 1 month 6 days
Weighted- Average Remaining Contractual Life, Exercisable 2 years 1 month 6 days